On October 6, 2016, the Pierre Fabre Foundation organized a conference in Lavaur (France) on the challenges of the fight against fake medicines in Africa and Asia. This conference shed scientific light on the scandal of fake medicines in southern countries. 1 in 10 medicines in circulation in the Third World are falsified, causing an estimated 800,000 deaths per year. This trafficking would even be the most lucrative source of organized crime, bringing in more than drugs. The quality and safety of medicines are debated, particularly in the least developed developing countries which represent only 2% of global health spending. Failures in the drug chain are amplified by a growing number of falsified drugs. In 2009, the WHO audited 22 national medicines regulatory agencies; only 3 were able to respond satisfactorily to the multifactorial evaluation criteria. Falsification, highly lucrative, represents, according to the WHO, 15% of the global drug market with significant African stigmatization which, depending on the country, can vary from 30 to 70% of national markets. In Africa, according to the World Health Organization (WHO), nearly 100,000 deaths per year are linked to the trade in counterfeit medicines. The British think tank International Policy Network estimates that fake TB and malaria drugs cause 700,000 deaths a year worldwide, the equivalent of “four jumbo jets full of passengers crashing every day.”
In order to contribute to the distribution of good medicines in the third world, the company Mbemba Zulu LLC was created in July 2023 in the south of the state of Vermont in the United States of America. Mr. Arsene Francoeur NGANGA, researcher in historical and social sciences and Mental health technician and nurse aid in the United States of America and immigrant from Congo-Brazzaville, stood up through this company in order to be able to bring authentic medicines from United states of America for the Third World. The United States, like the countries of Western Europe, benefits from a high level of Hygiene, which combines with surveillance measures, with the powerful FDA (American Medicines Agency of the United States). Mbemba Zulu proposes to present an alternative for reliable medicines and cosmetics in the third world through the promotion of American medicines and cosmetics.